Supplementary Fig S5 from Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer

Figure shows changes in LBx-BCM methylation in response to chemotherapy in 7 additional patient longitudinal serial samples. LBx-BCM was performed and cumulative methylation (CM) (Y-axis) is plotted from serum samples drawn at baseline (0 days) and immediately before each treatment cycle (X-axis). For each patient, treatment cycles are shown as a shaded area. PD, progressive disease; SD, stable disease (SD).